Structure via PubChem · Public domain (PubChem)
nystatin
Sign in to saveNystatin, sold under the brand name Mycostatin among others, is an antifungal medication. It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or applied to the skin.
Key facts
- Drug.IUPAC_name
- (1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E, 25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-β-L-mannopyranosyl)oxy]-1, 3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14, 39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
- Drug.C
- 47
- Drug.H
- 75
- Drug.N
- 1
- Drug.O
- 17
- Drug.SMILES
- CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
- Drug.StdInChI
- 1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1
- Drug.StdInChIKey
- VQOXZBDYSJBXMA-NQTDYLQESA-N
- Drug.melting_point
- 44-46
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458776717
- Drug.image
- Nystatin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 300
- Drug.image2
- Nystatin ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Mycostatin, others
via Wikipedia infobox
Chemical data
- Formula
- C47H75NO17
- Molecular weight
- 926.1 g/mol
- IUPAC name
- (1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2S,3R,4R,5R,6S)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
- SMILES
- C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)N)O
- InChIKey
- VQOXZBDYSJBXMA-VHFLTRTASA-N
- XLogP
- -0.2
- Polar surface area
- 320 Ų
- H-bond donors
- 12
- H-bond acceptors
- 18
- Formal charge
- 0
via PubChem
Research
5,895 papers- Nystatin.The Medical clinics of North America · 1970
- Nystatin.Annals of the New York Academy of Sciences · 1960
- The Persistence of Nystatin Use for Dermatophyte Infections.Journal of drugs in dermatology : JDD · 2023
- Nystatin LF (Aronex/Abbott).Current opinion in investigational drugs (London, England : 2000) · 2001
- Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis.Drug design, development and therapy · 2016
via PubMed
Clinical Trials
22 registered- PHASE4COMPLETEDAntifungal Prophylaxis in Intensive Care Unit (ICU) PatientsPoliclinico Hospital · NCT01495039
- PHASE3COMPLETEDMagic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced MucositisJuravinski Cancer Centre Foundation · NCT00814359
- NACOMPLETEDComparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency SyndromePfizer · NCT00002112
- NACOMPLETEDA Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related SyndromesBristol-Myers Squibb · NCT00002293
- PHASE3COMPLETEDA Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious VaginosisJanssen-Cilag, S.A. · NCT01867164
- NACOMPLETEDNystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARCBristol-Myers Squibb · NCT00002057
Wikidata facts
- Mass
- 925.5035
Show 5 more facts
- chemical formula
- C₄₇H₇₅NO₁₇
- World Health Organisation international non-proprietary name
- nystatin
- canonical SMILES
- CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
- NCI Thesaurus ID
- C710
- Commons category
- Nystatin
via Wikidata · CC0
~12 min read
Article
9 sectionsContents
- Medical uses
- Adverse effects
- Mechanism of action
- Biosynthesis
- History
- Other uses
- Formulations
- Brand names
- References
Nystatin, sold under the brand name Mycostatin among others, is an antifungal medication. It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or applied to the skin.
Common side effects when applied to the skin include burning, itching, and a rash. Common side effects when taken by mouth include vomiting and diarrhea. During pregnancy use in the vagina is safe while other formulations have not been studied in this group. It works by disrupting the cell membrane of the fungal cells.